Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia
Top Cited Papers
- 21 August 2006
- journal article
- review article
- Published by Wiley in Experimental Physiology
- Vol. 91 (5), 807-819
- https://doi.org/10.1113/expphysiol.2006.033506
Abstract
All eukaryotic cells utilize oxidative phosphorylation to maintain their high-energy phosphate stores. Mitochondrial oxygen consumption is required for ATP generation, and cell survival is threatened when cells are deprived of O2. Consequently, all cells have the ability to sense O2, and to activate adaptive processes that will enhance the likelihood of survival in anticipation that oxygen availability might become limiting. Mitochondria have long been considered a likely site of oxygen sensing, and we propose that the electron transport chain acts as an O2 sensor by releasing reactive oxygen species (ROS) in response to hypoxia. The ROS released during hypoxia act as signalling agents that trigger diverse functional responses, including activation of gene expression through the stabilization of the transcription factor hypoxia-inducible factor (HIF)-α. The primary site of ROS production during hypoxia appears to be complex III. The paradoxical increase in ROS production during hypoxia may be explained by an effect of O2 within the mitochondrial inner membrane on: (a) the lifetime of the ubisemiquinone radical in complex III; (b) the relative release of mitochondrial ROS towards the matrix compartment versus the intermembrane space; or (c) the ability of O2 to access the ubisemiquinone radical in complex III. In summary, the process of oxygen sensing is of fundamental importance in biology. An ability to control the oxygen sensing mechanism in cells, potentially using small molecules that do not disrupt oxygen consumption, would open valuable therapeutic avenues that could have a profound impact on a diverse range of diseases.Keywords
This publication has 86 references indexed in Scilit:
- Role of ETS Transcription Factors in the Hypoxia-Inducible Factor-2 Target Gene SelectionCancer Research, 2006
- Hypoxia-inducible factor-1 (HIF-1)Critical Care Medicine, 2005
- Activation of the Redox-regulated Chaperone Hsp33 by Domain UnfoldingJournal of Biological Chemistry, 2004
- Hypoxia-Induced Gene Expression Occurs Solely through the Action of Hypoxia-Inducible Factor 1α (HIF-1α): Role of Cytoplasmic Trapping of HIF-2αMolecular and Cellular Biology, 2003
- Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profilingOncogene, 2000
- An out-of-frame cytochromeb gene deletion from a patient with parkinsonism is associated with impaired complex III assembly and an increase in free radical productionAnnals of Neurology, 2000
- Mechanism of regulation of the hypoxia-inducible factor-1alpha by the von Hippel-Lindau tumor suppressor proteinThe EMBO Journal, 2000
- Cells depleted of mitochondrial DNA (p0) yield insight into physiological mechanismsFEBS Letters, 1999
- Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1αGenes & Development, 1998
- Regulation of cellular energy metabolismThe Journal of Membrane Biology, 1982